UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043462
Receipt number R000049631
Scientific Title Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid
Date of disclosure of the study information 2021/03/01
Last modified on 2022/03/01 11:43:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Acronym

Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Scientific Title

Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Scientific Title:Acronym

Prenatal diagnosis of mucolipidosis II using fetal cells in amniotic fluid

Region

Japan


Condition

Condition

Mucolipidosis II

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To diagnose mucolipidosis II using fetal cells in amniotic fluid

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

whether fetus will be affected or not

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Gene

Interventions/Control_1

PCR and direct sequencing of the affected gene (GNPT) and indirect diagnosis using microsatellite analysis or Karyomapping

Interventions/Control_2

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Pregnant woman who previously delivered the baby with mucolipidosis II

Key exclusion criteria

nothing

Target sample size

1


Research contact person

Name of lead principal investigator

1st name Tsuyoshi
Middle name
Last name Baba

Organization

Sapporo Medical University

Division name

Obstetrics and Gynecology

Zip code

060-8543

Address

South 1 West 16, Sapporo, Hokkaido

TEL

0116112111

Email

tbaba@sapmed.ac.jp


Public contact

Name of contact person

1st name Tsuyoshi
Middle name
Last name Baba

Organization

Sapporo Medical University

Division name

Obstetrics and Gynecology

Zip code

0608543

Address

South 1 West 16, Sapporo, Hokkaido

TEL

011-611-2111

Homepage URL


Email

tbaba@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board at Sapporo Medical University

Address

South 1 West 16, Sapporo, Hokkaido

Tel

011-611-2111

Email

ji-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 07 Month 01 Day

Date of IRB

2017 Year 09 Month 14 Day

Anticipated trial start date

2017 Year 09 Month 14 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 28 Day

Last modified on

2022 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049631


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name